Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical -Q1 group results

Apr 28 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2020        Mar 31, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             31.91               31.68           165.00    
                 (+0.7 pct)                           (+4.2 pct)  
  Operating          4.88                5.15            26.40    
                 (-5.3 pct)                           (+2.9 pct)  
  Recurring          5.04                5.22            28.00    
                 (-3.4 pct)                           (+0.5 pct)  
  Net                3.74                3.68            20.00    
                 (+1.6 pct)                           (+4.5 pct)  
  EPS             47.89 yen           46.65 yen       255.88 yen  
  Ann Div                             73.00 yen        75.00 yen  
  -Q2 div                             33.00 yen        34.00 yen  
  -Q4 div                             40.00 yen        41.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news